High-performance liquid chromatographic assay for the separation and characterization of metabolites of the potential cytostatic drug oracine

Journal of Chromatography B: Biomedical Applications

Volumn 681, Issue 1, 1996, Pages 169-175

  Wsol V ^a   Kvasnickova E ^a   Szotakova B ^a   Hais, I M ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Oracine

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; DRUG FECES LEVEL; DRUG IDENTIFICATION; DRUG METABOLISM; DRUG URINE LEVEL; LIVER CELL; LIVER METABOLISM; LIVER MICROSOME; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; THIN LAYER CHROMATOGRAPHY; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 0342592199     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-4347(96)00066-7     Document Type: Conference Paper

References (8)

1. M. Mělka, Screening Evaluation, Research Report VÚFB, 1987.
2. J. Michalský, Int. Pat. Appl., PCT/CS92/00026.
3. J. Jirman, O. Kašpar and A. Koloničný, in preparation.
4. J.R. Gillette, in B.N. LaDu, H.G. Mandel and E.L. Way (Editors), Fundamentals of Drug Metabolism and Drug Disposition, The Williams and Wilkins Company, Baltimore, MD, 1972 pp. 400-418.
5. M.D. Berry and D.S. Friend, J. Cell Biol., 43 (1969) 506.
6. E. Kvasničková, M. Nobilis, A. Šroler, E. Báčová and I.M. Hais, J. Chromatogr., 387 (1987) 559.
7. V. Wsól, B.J. Clark and E. Kvasničková, Proceedings of the 7th Meeting on Stereochemistry, Czech Chem. Soc., Třešt', 1985, p. 99.
8. V. Wsól, B.J. Clark, E. Kvasničková and I.M. Hais, in European Conference on Specificity and Variability in Drug Metabolism, European Concerted Action COST B1, Besançon 1995, Abstract 64.